Related Experiment Video
Updated: Jul 17, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Burden of Antimicrobial Resistance in Japan: A Systematic Literature Review and Meta-Analysis
Tetsuya Matsumoto1, Akira Yuasa2, Hiroyuki Matsuda3
1Department of Infectious Diseases, School of Medicine, International University of Health and Welfare, Narita, Japan.
Introduction:
Antimicrobial resistance (AMR) is one of the most serious public health challenges worldwide, including in Japan. However, there is limited evidence assessing the AMR burden in Japan. Thus, this systematic literature review (SLR) and meta-analysis (MA) were conducted to assess the clinical and economic burden of AMR in Japan.
Methods:
Comprehensive literature searches were performed on EMBASE, MEDLINE, the Cochrane Library, and ICHUSHI between 2012 and 2022 following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. MA estimated a pooled effect between the two comparative arms (AMR vs. non-AMR). The results were reported in measures of odds ratios (ORs) for in-hospital mortality and in standardized mean differences (SMDs) for length of stay (LOS) and direct medical costs.
Results:
Literature searches identified 1256 de-duplicated records, of which 56 observational studies (English, n = 35; Japanese, n = 21) were included. Of note, twenty-two studies (39.3%) compared the AMR group with non-AMR group. In the SLR, in-hospital mortality, LOS, and direct medical costs were higher in the AMR group compared to the non-AMR group. Eight studies were selected for the MA. In the AMR group, the pooled estimate showed a statistically higher in-hospital mortality [random effect (RE)-OR 2.25, 95% CI 1.34-3.79; I2 = 89%; τ2 = 0.2257, p < 0.01], LOS (RE-SMD 0.37, 95% CI - 0.09-0.84; I2 = 99%; τ2 = 0.3600, p < 0.01), and direct medical cost (RE-SMD 0.53, 95% CI 0.43-0.62; I2 = 0.0%; τ2 = 0.0, p = 0.88) versus the non-AMR group.
Conclusion:
Our study presents an overview of the clinical and economic burden of AMR in Japan. Patients with AMR infections experience significantly higher in-hospital mortality, LOS, and direct medical costs compared with patients without AMR infections.
Insights
Antimicrobial resistance (AMR) in Japan significantly increases in-hospital mortality, length of stay, and medical costs. This systematic review and meta-analysis quantifies the substantial clinical and economic burden of AMR infections.
Area of Science:
- Public Health
- Infectious Diseases
- Health Economics
Background:
- Antimicrobial resistance (AMR) poses a significant global public health threat, with a notable impact in Japan.
- Limited evidence exists on the specific burden of AMR within Japan.
- This study addresses the knowledge gap by assessing the clinical and economic consequences of AMR in Japan.
Purpose of the Study:
- To systematically review and meta-analyze existing literature on the clinical and economic burden of AMR in Japan.
- To quantify the impact of AMR on in-hospital mortality, length of hospital stay, and direct medical costs.
- To provide evidence for public health strategies and resource allocation in Japan.
Main Methods:
- Conducted comprehensive literature searches across EMBASE, MEDLINE, Cochrane Library, and ICHUSHI (2012-2022).
- Adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines.
- Performed meta-analysis to estimate pooled effects (ORs for mortality, SMDs for LOS and costs) comparing AMR vs. non-AMR groups.
Main Results:
- Included 56 observational studies (35 English, 21 Japanese); 22 studies directly compared AMR and non-AMR groups.
- Systematic literature review indicated higher in-hospital mortality, length of stay (LOS), and direct medical costs in the AMR group.
- Meta-analysis of 8 studies confirmed significantly higher in-hospital mortality (RE-OR 2.25), LOS (RE-SMD 0.37), and direct medical costs (RE-SMD 0.53) in patients with AMR infections.
Conclusions:
- This study provides a comprehensive overview of the clinical and economic burden of AMR in Japan.
- Patients with AMR infections face demonstrably higher in-hospital mortality, prolonged hospital stays, and increased direct medical costs.
- Findings underscore the urgent need for effective AMR containment strategies in Japan.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
06:54Author Spotlight: Understanding and Detecting Environmental Antimicrobial Resistance by Combining Culture-Based Techniques and Genomics
Published on: July 19, 2024
Related Concept Videos
Antibiotic Selection
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Antimicrobial Effectiveness
Production of Antibiotics
Clinical Significance of Antibiotic Resistance